Cerillo is a dynamic player in the Biotechnology and Life Sciences industries, dedicated to revolutionizing cellular analytics through its suite of innovative discovery tools. Founded in 2016 and headquartered in the United States, the company aims to bridge the gap between persistent research efforts and groundbreaking innovations.
The company positions itself as a dedicated partner to researchers, providing technology that enhances efficiency and agility while enabling scientists to approach problems from innovative perspectives. Cerillo's commitment to continuous innovation helps transform potential discoveries into world-changing breakthroughs.
The startup's most recent financial milestone was a $1.34M Seed Round investment on 16 August 2021, with participation from CAV Angels. This funding underscores investors' confidence in Cerillo's mission to be a critical catalyst in the realm of laboratory transformations.